Cytometry Part B-Clinical Cytometry

Papers
(The median citation count of Cytometry Part B-Clinical Cytometry is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
Mass cytometric single cell immune profiles of peripheral blood from acute myeloid leukemia patients in complete remission with measurable residual disease31
Erythroid side scatter: A parameter that improves diagnostic accuracy of flow cytometry myelodysplastic syndrome scoring30
Issue highlights—January 202529
The role of the primitive marker CD133 in CD34‐negative acute myeloid leukemia for the detection of leukemia stem cells27
23
Phenotype and oxidative burst of low‐density neutrophil subpopulations are altered in common variable immunodeficiency patients18
Issue highlights—September 202316
Issue Information15
15
14
Issue Information13
Addition of CD14 improves discrimination of lymphocytes in the TBNK phenotyping panel11
Standardization of flow cytometric detection of antigen expression11
Machine learning optimized multiparameter radar plots for B‐cell acute lymphoblastic leukemia minimal residual disease analysis11
Utility of leukocyte‐associated immunoglobulin‐like receptor‐1 (CD305) in flow cytometric detection of minimal bone marrow involvement by B‐cell non‐Hodgkin lymphoma11
Issue Information10
Validation of a new multiparametric protocol to assess viability, acrosome integrity and mitochondrial activity in cooled and frozen thawed boar spermatozoa10
Increased TOX expression concurrent with PD‐1, Tim‐3, and CD244 expression in T cells from patients with acute myeloid leukemia9
ROR1 expression in mature B lymphoid neoplasms by flow cytometry9
CD133 in T‐lymphoblastic leukemia is preferentially expressed in early T‐phenotype (ETP) and near ETP subtypes9
Issue Highlights—January 20229
Issue Information9
Issue Information8
Issue Highlights — May 20218
Malignant plasmacytes in bone marrow detected by flow cytometry as a predictor for the risk stratification system of multiple myeloma8
Issue Information8
Converting an HLA‐B27 flow assay from the BD FACSCanto to the BD FACSLyric7
Abnormal B‐lymphoblasts in myelodysplastic syndromes and myeloproliferative neoplasms other than chronic myeloid leukemia7
Integration of T‐cell clonality screening using TRBC‐1 in lymphoma suspect samples by flow cytometry7
Whole blood no‐lyse no‐wash micromethod for the quantitative measurement of monocyte HLA‐DR7
Correction to “Clinical application of flow cytometry in patients with unexplained cytopenia and suspected myelodysplastic syndrome: A report of the European LeukemiaNet International 6
Alignment, segmentation and neighborhood analysis in cyclic immunohistochemistry data using CASSATT6
Clinical application of flow cytometry in patients with unexplained cytopenia and suspected myelodysplastic syndrome: A report of the European LeukemiaNet International MDS‐Flow 6
Enhancing HLA‐B27 antigen detection: Leveraging machine learning algorithms for flow cytometric analysis6
Summary of validation considerations with real‐life examples using both qualitative and semiquantitative flow cytometry assays6
6
SingletSeeker: an unsupervised clustering approach for automated singlet discrimination in cytometry6
Performance of a novel eight‐color flow cytometry panel for measurable residual disease assessment of chronic lymphocytic leukemia6
5
Appropriate interpretation of TRBC1‐dim positive subsets in T‐cell immunophenotyping by flow cytometry5
Monocyte HLA‐DR expression as an enrollment biomarker in sepsis clinical trials: Evaluation of two sampling tubes and definition of respective clinical thresholds5
Bone marrow follicular‐like T cells in monoclonal gammopathies5
5
Editorial on IVD cellular assay validation5
Possible alternative strategies to implement basophil activation testing in multicentric studies5
Quick identification of target antigens by tissue flow cytometry for CAR‐T therapy in B‐cell malignancies5
Issue Information5
5
Extranodal NK/T‐cell lymphoma with isolated central nervous system relapse: A defiant disease and the role of flow cytometry in monitoring5
Imaging flow cytometry reveals a subset of TdT negative T‐ALL blasts with very low forward scatter on conventional flow cytometry5
Clinical significance of end of induction measurable residual disease monitoring in B‐cell acute lymphoblastic leukemia: A single center experience4
The patterns and diagnostic significance of the lack of surface immunoglobulin light chain on mature B cells in clinical samples for lymphoma workup4
Issue Information4
Automated analysis of flow cytometry data with minimal training files: Research evaluation of an elastic image registration algorithm for TBNK, stem cell enumeration, and lymphoid screening4
Glucose‐6‐phosphate dehydrogenase deficiency detection using fluorocytometric assay: Evaluation after 1 year of clinical implementation4
Patients without cutaneous T‐cell lymphoma frequently harbor CD4 T‐lymphocytes that lack CD26 and/or CD74
Issue Highlights—July 20224
Flow cytometric analysis of myelodysplasia: Pre‐analytical and technical issues—Recommendations from the European LeukemiaNet4
Analysis of human chromosomes by imaging flow cytometry4
Implementation of beaker CP for flow cytometry: Workflow optimization and integration at Stanford Health Care3
CD38, CD39, and BCL2 differentiate disseminated forms of high‐grade B‐cell lymphomas in biological fluids from Burkitt lymphoma and diffuse large B‐cell lymphoma3
Flow cytometric immunophenotyping of plasma cells across the spectrum of plasma cell proliferative disorders: A fresh insight with pattern‐based recognition3
Increased IFN‐γ+ and TNF‐α+ mucosal‐associated invariant T cells in patients with aplastic anemia3
Issue Highlights—November 20213
Bicentric evaluation of stabilizing sampling tubes for assessment of monocyte HLA‐DR expression in clinical samples3
A lasso and random forest model using flow cytometry data identifies primary myelofibrosis3
PD‐1 improves accurate detection of Sezary cells by flow cytometry in peripheral blood in mycosis fungoides/Sezary syndrome3
Issue highlights—May 20232
The use of erythrocytes as biomarkers with a timeline2
A comparison and review of the flow cytometric findings in classic Hodgkin lymphoma, nodular lymphocyte predominant Hodgkin lymphoma, T cell/histiocyte rich large B cell lymphoma, and primary mediasti2
Spurious CD34 expression in B‐cell lymphoma due to nonspecific binding to PerCP‐Cy5.5 fluorochrome conjugates: A rare phenomenon and a diagnostic pitfall2
Enhancing lymphoma diagnosis on core needle biopsies: Integrating immunohistochemistry with flow cytometry2
28‐color single tube for flow cytometric assessment of myeloid maturation, myeloid neoplasia, and acute myeloid leukemia minimal/measurable residual disease2
Flow cytometric analysis of CD34+CD38− cells; cell frequency and immunophenotype based on CD45RA expression pattern2
Hierarchical clustering of clinical and flow cytometry parameters is associated with deterioration in patients with community‐acquired pneumonia in the emergency department: A preliminary study2
Issue highlights—July 20242
Issue Information2
Use of a hybrid intelligence decision tree to identify mature B‐cell neoplasms2
Role of flow cytometric immunophenotyping in the diagnosis of breast implant‐associated anaplastic large cell lymphoma: A 6‐year, single‐institution experience2
2
Issue highlights—November 20242
Expression levels and patterns of B‐cell maturation antigen in newly diagnosed and relapsed multiple myeloma patients from Indian subcontinent2
Translating the regulatory landscape of medical devices to create fit‐for‐purpose artificial intelligence (AI) cytometry solutions2
Issue Highlights—March 20222
Flow cytometry in the diagnosis of myelodysplastic syndromes2
Concomitant cutaneous T‐cell lymphoma and biclonal B‐cell lymphoproliferative disorder2
Correlation between a 10‐color flow cytometric measurable residual disease (MRD) analysis and molecular MRD in adult B‐acute lymphoblastic leukemia2
Issue Information2
Prospective feasibility of a minimal BH3 profiling assay in acute myeloid leukemia2
Flow cytometric immunophenotypic differentiation patterns of bone marrow eosinophilopoiesis2
2
Use of flow cytometry and cytology to differentiate breast implant‐associated anaplastic large cell lymphoma from reactive seromas in Brazilian patients2
2
2
Noel Warner Ph.D.1
Issue highlights—February 20241
1
Flow cytometry immunophenotypic features of pure erythroid leukemia and the distinction from reactive erythroid precursors1
Where diagnosis for myelodysplastic neoplasms (MDS) stands today and where it will go: The role of flow cytometry in evaluation of MDS1
Flow cytometry for meningeal infiltration in B acute lymphoblastic leukemia in a low middle income country1
Issue Information1
External quality assessment of flow cytometric bronchoalveolar lavage cellular analysis: 20 years' experience in The Netherlands1
Immunophenotypic characteristics of ZNF384 rearrangement compared with BCR‐ABL1, KMT2A rearrangement, and other adult B‐cell precursor 1
Analytical assay validation for acute myeloid leukemia measurable residual disease assessment by multiparametric flow cytometry1
IgE‐mediated bleomycin hypersensitivity: Evidence from drug‐reactive T lymphocytes1
1
Partial recapitulation of fetal thymic T‐cell constitution postnatally in a patient with cartilage hair hypoplasia‐anauxetic dysplasia spectrum disorder: A case report1
A series of case studies illustrating the role of flow cytometry in the diagnostic work‐up of myelodysplastic syndromes1
Flow cytometry of DNMT1 as a biomarker of hypomethylating therapies1
Differentiating reactive and neoplastic gamma‐delta (γδ) T‐cell expansions in the peripheral blood and bone marrow1
Issue Information1
Clinical validation of a real‐time machine learning‐based system for the detection of acute myeloid leukemia by flow cytometry1
Issue Information1
Comparison of three machine learning algorithms for classification of B‐cell neoplasms using clinical flow cytometry data1
1
Clinical, immunophenotypic, and cytogenetic characteristics of high‐grade myelodysplastic syndromes with CD41‐positive progenitor cells1
Issue Highlights—September 20221
Issue Highlights—May 20221
Transient abnormal lymphomyelopoiesis in a newborn with PTPN11 mutation associated Noonan syndrome1
1
Peripheral T‐cell lymphoma immunophenotype in a patient with a history of Muromonab‐CD3 therapy: A case report and a diagnostic dilemma1
Automation in flow cytometry: Guidelines and review of systems1
Validation of a 12‐color flow cytometry assay for acute myeloid leukemia minimal/measurable residual disease detection1
1
Automated quantification of measurable residual disease in chronic lymphocytic leukemia using an artificial intelligence‐assisted workflow1
Myeloid sarcoma or mixed phenotype acute leukemia? Multiparametric flow cytometry to the rescue in an unusual diagnostic dilemma1
Log reduction of leukemic cells and minimal residual disease by flow cytometry represent effective predictors of clinical outcome in elderly patients with acute myeloid leukemia1
Technical, gating and interpretation recommendations for the partitioning of circulating monocyte subsets assessed by flow cytometry1
Issue Information1
Immunophenotypic portrait of leukemia‐associated‐phenotype markers in B acute lymphoblastic leukemia1
European flow cytometry quality assurance guidelines for the diagnosis of primary immune deficiencies and assessment of immune reconstitution following B cell depletion therapies and transp1
Maturational dyssynchrony in benign B‐cell precursors following lymphocyte depleting chemotherapy: A potential pitfall for B‐lymphoblastic leukemia minimal/measurable residual di1
The role of CD20+ T cells: Insights in human peripheral blood1
Optimization of monocyte gating to quantify monocyte subsets for the diagnosis of chronic myelomonocytic leukemia1
Characterization of myelodysplastic syndromes hematopoietic stem and progenitor cells using mass cytometry1
Issue highlights—July 20231
Issue highlights—November 20221
Issue highlights—September 20241
Longitudinal monitoring of class‐switched memory‐B cell proportions identifies plausible germinal center failure in patients with suspected immune disorders1
Recommendations for using artificial intelligence in clinical flow cytometry1
Dual peaks on flow cytometric DNA ploidy analysis in chronic lymphocytic leukemia with Richter transformation1
Flow cytometric assessment for minimal/measurable residual disease in B lymphoblastic leukemia/lymphoma in the era of immunotherapy1
Urinary red blood cell‐derived microparticles and phosphatidylserine‐exposing red blood cells in glomerular and non‐glomerular hematuria patients1
0.085625171661377